Discussion on toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis [6] (multiple letters)

Gastroenterology

Volumn 127, Issue 1, 2004, Pages 366-367

  Reid, Gregor ^a   Guarner, Francisco ^b   Gibson, Glenn ^c   Tompkins, Thomas ^d   Gill, Harsharn ^e   Rowland, Ian ^f   Rastall, Bob ^f   Pot, Bruno ^g   Sanders, Mary Ellen ^h,i   Rachmilewitz, Daniel ^j   Raz, Eyal ^k  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^c UNIVERSITY OF READING   (United Kingdom)

^d LALLEMAND SAS   (France)

^e DEPARTMENT OF PRIMARY INDUSTRIES   (Australia)

^f UNIVERSITY OF ULSTER   (United Kingdom)

^g GHENT UNIVERSITY   (Belgium)

^h DAIRY AND FOOD CULTURE TECHNOLOGIES   (United States)

ⁱ Shaare Zedek Medical Center ^*

^j SHAARE ZEDEK MEDICAL CENTER   (Israel)

^k UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; PROBIOTIC AGENT; TOLL LIKE RECEPTOR 9;

ANTIINFLAMMATORY ACTIVITY; ATTENUATION; COLITIS; CPG ISLAND; CYTOKINE PRODUCTION; DISEASE SEVERITY; HEALTH CARE; HEALTH PRACTITIONER; HISTOLOGY; HUMAN; IMMUNOMODULATION; INFLAMMATION; LETTER; MEDICAL LITERATURE; MEDICAL RESEARCH; MICROORGANISM; NONHUMAN; PRIORITY JOURNAL; PUBLICATION; SCORING SYSTEM; SIGNAL TRANSDUCTION;

EID: 3242655747     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2004.05.052     Document Type: Letter

References (10)

1. D. Rachmilewitz K. Katakura F. Karmeli T. Hayashi C. Reinus B. Rudensky S. Akira K. Takeda J. Lee K. Takabayashi E. Raz Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis Gastroenterology 126 2004 520 528
2. R. Atreya J. Mudter S. Finotto J. Mullberg T. Jostock S. Wirtz M. Schutz B. Bartsch M. Holtmann C. Becker D. Strand J. Czaja J.F. Schlaak H.A. Lehr F. Autschbach G. Schurmann N. Nishimoto K. Yoshizaki H. Ito T. Kishimoto P.R. Galle S. Rose-John M.F. Neurath Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation evidence in Crohn’s disease and experimental colitis in vivo Nat Med 6 2000 583 588
3. A. Stallmach T. Marth B. Weiss B.M. Wittig A. Hombach C. Schmidt M. Neurath M. Zeitz S. Zeuzem H. Abken An interleukin 12 p40-IgG2b fusion protein abrogates T cell mediated inflammation anti-inflammatory activity in Crohn’s disease and experimental colitis in vivo Gut 53 2004 339 345
4. F. Obermeier N. Dunger L. Deml H. Herfarth J. Schölmerich W. Falk CpG motifs of bacterial DNA exacerbate colitis of dextran sulfate sodium-treated mice Eur J Immunol 32 2002 2084 2092
5. F. Obermeier N. Dunger U.G. Strauch N. Grunwald H. Herfarth J. Scholmerich W. Falk Contrasting activity of cytosin-guanosin dinucleotide oligonucleotides in mice with experimental colitis Clin Exp Immunol 134 2003 217 224
6. J.M. Hamilton-Miller S. Shah J.T. Winkler Public health issues arising from microbiological and labelling quality of foods and supplements containing probiotic microorganisms Public Health Nutr 2 1999 223 229
7. S. Pathmakanthan C.K. Li J. Cowie C.J. Hawkey Lactobacillus plantarum 299 Beneficial in vitro immunomodulation in cells extracted from inflamed human colon J Gastroenterol Hepatol 19 2004 166 173
8. O. Shibolet F. Karmeli R. Eliakim E. Swennen P. Brigidi P. Gionchetti M. Campieri S. Morgenstern D. Rachmilewitz Variable response to probiotics in two models of experimental colitis in rats Inflamm Bowel Dis 8 2002 399 406
9. G. Reid M.E. Sanders H.R. Gaskins G.R. Gibson A. Mercenier R. Rastall M. Roberfroid I. Rowland C. Cherbut T.R. Klaenhammer New scientific paradigms for probiotics and prebiotics J Clin Gastroenterol 37 2003 105 118
10. M. Hopkin Probiotic bacteria health boon Nature 427 2004 284 286